These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Efficacy and indication optimization of Chinese medicine (Tiao-Chang Ke-Min granules) for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized controlled trial. Li Q; Zhang BP; Huang SG; Ouyang WW; Xie JH; Wen ZH; Yang XB Trials; 2018 Jul; 19(1):367. PubMed ID: 29996882 [TBL] [Abstract][Full Text] [Related]
7. Reports of "satisfactory relief" by IBS patients receiving usual medical care are confounded by baseline symptom severity and do not accurately reflect symptom improvement. Whitehead WE; Palsson OS; Levy RL; Feld AD; VonKorff M; Turner M Am J Gastroenterol; 2006 May; 101(5):1057-65. PubMed ID: 16573774 [TBL] [Abstract][Full Text] [Related]
8. Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study. Dove LS; Lembo A; Randall CW; Fogel R; Andrae D; Davenport JM; McIntyre G; Almenoff JS; Covington PS Gastroenterology; 2013 Aug; 145(2):329-38.e1. PubMed ID: 23583433 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials. Rahimi R; Nikfar S; Abdollahi M Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of enteric coated capsules of anise oil to treat irritable bowel syndrome. Mosaffa-Jahromi M; Lankarani KB; Pasalar M; Afsharypuor S; Tamaddon AM J Ethnopharmacol; 2016 Dec; 194():937-946. PubMed ID: 27815079 [TBL] [Abstract][Full Text] [Related]
11. Item-level assessment of the irritable bowel syndrome quality of life questionnaire in patients with diarrheal irritable bowel syndrome. Andrae DA; Covington PS; Patrick DL Clin Ther; 2014 May; 36(5):663-79. PubMed ID: 24813429 [TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial of a cognitive behavioural therapy-based self-management intervention for irritable bowel syndrome in primary care. Moss-Morris R; McAlpine L; Didsbury LP; Spence MJ Psychol Med; 2010 Jan; 40(1):85-94. PubMed ID: 19531276 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of Achillea wilhelmsii C. Koch capsules on symptom severity and quality of life in patients with irritable bowel syndrome: a randomized, placebo-controlled clinical trial. Derakhshande P; Navabi SJ; Shokoohinia Y; Rouhi-Broujeni H; Deris F; Behbood L; Shahbazi F; Amiri M; Farzaei MH J Complement Integr Med; 2019 Aug; 16(4):. PubMed ID: 31442203 [TBL] [Abstract][Full Text] [Related]
14. The Short Health Scale: A Simple, Valid, Reliable, and Responsive Way of Measuring Subjective Health in Patients With Irritable Bowel Syndrome. Krarup AL; Peterson E; Ringström G; Törnblom H; Hjortswang H; Simrén M J Clin Gastroenterol; 2015 Aug; 49(7):565-70. PubMed ID: 25216385 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of ramosetron in the treatment of male patients with irritable bowel syndrome with diarrhea: a multicenter, randomized clinical trial, compared with mebeverine. Lee KJ; Kim NY; Kwon JK; Huh KC; Lee OY; Lee JS; Choi SC; Sohn CI; Myung SJ; Park HJ; Choi MK; Bak YT; Rhee PL Neurogastroenterol Motil; 2011 Dec; 23(12):1098-104. PubMed ID: 21920001 [TBL] [Abstract][Full Text] [Related]
16. Peppermint oil for the treatment of irritable bowel syndrome: a systematic review and meta-analysis. Khanna R; MacDonald JK; Levesque BG J Clin Gastroenterol; 2014 Jul; 48(6):505-12. PubMed ID: 24100754 [TBL] [Abstract][Full Text] [Related]
17. A Novel Delivery System of Peppermint Oil Is an Effective Therapy for Irritable Bowel Syndrome Symptoms. Cash BD; Epstein MS; Shah SM Dig Dis Sci; 2016 Feb; 61(2):560-71. PubMed ID: 26319955 [TBL] [Abstract][Full Text] [Related]
18. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial. Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995 [TBL] [Abstract][Full Text] [Related]
19. A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome. Nyhlin H; Bang C; Elsborg L; Silvennoinen J; Holme I; Rüegg P; Jones J; Wagner A Scand J Gastroenterol; 2004 Feb; 39(2):119-26. PubMed ID: 15000272 [TBL] [Abstract][Full Text] [Related]